Welcome to our dedicated page for Cuprina Holdings (Cayman) SEC filings (Ticker: CUPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cuprina Holdings (Cayman) Limited filings document a foreign private issuer developing and marketing biomedical products across chronic wounds, infertility, medical waste recycling and cosmeceuticals. Its Form 6-K reports furnish press releases and material updates on MEDIFLY regulatory classification, wound care collaborations, medical waste recycling licenses, scientific advisory activity and research-related announcements.
The company's regulatory record also covers annual general meeting materials, proxy voting matters, director elections, auditor appointments, an employee incentive plan, amended memorandum and articles of association, board and officer changes, and ordinary-share public-company governance. These filings provide formal disclosure around Cuprina's operating initiatives, governance structure, accounting oversight and capital-market reporting status.
Cuprina Holdings (Cayman) Limited has regained compliance with Nasdaq’s listing requirements, ensuring its Class A Ordinary Shares remain listed and traded on the Nasdaq Capital Market under the symbol CUPR. The company had previously fallen below the $1.00 minimum bid price for 30 consecutive business days and did not regain compliance within the initial 180-day grace period ending May 26, 2026, triggering a Staff Delisting Determination and a planned hearing. Nasdaq Listing Qualifications staff have now advised that the company again meets the minimum bid requirement, so the July 7, 2026 hearing has been cancelled.
Cuprina Holdings (Cayman) Limited reported the results of its 2026 annual shareholder meeting. Shareholders reappointed J&S Associate PLT as auditor and re‑elected all director nominees. The meeting covered both routine governance and significant capital structure changes.
Investors approved a share consolidation that reduces issued Class A shares from 7,365,000 to 920,625 and issued Class B shares from 14,085,000 to 1,760,625, while keeping total authorised capital at US$50,000. They also backed increasing Class B voting rights from 10 to 100 votes per share and doubling authorised capital to US$100,000, split evenly between Class A and B.
Shareholders adopted a new Second Amended and Restated Memorandum and Articles of Association, approved the Cuprina 2026 Employee Incentive Plan, authorised potential future issuances that may result in a change of control or issuance of at least 20% of outstanding Class A shares, and allowed adjournment of the meeting if more proxy votes are needed.
Cuprina Holdings (Cayman) Limited files an amended report to update details for its May 14, 2026 annual general meeting. Shareholders are asked to appoint J&S Associate PLT as auditor, re-elect six directors and approve several capital and governance changes.
The board proposes a share consolidation so 7,365,000 issued Class A shares become 920,625 shares and 14,085,000 issued Class B shares become 1,760,625 shares, raising par value from US$0.001 to US$0.008 while keeping total authorised capital at US$50,000 initially. This reverse split is aimed at regaining compliance with Nasdaq’s US$1.00 minimum bid price rule before a May 26, 2026 deadline.
Proposals also include increasing Class B voting rights from 10 to 100 votes per share, doubling authorised capital to US$100,000 divided into 12,500,000 ordinary shares, adopting a Second Amended and Restated Memorandum and Articles, approving the Cuprina 2026 Employee Incentive Plan covering up to 15% of issued Class A shares, and authorising future share issuances that could exceed 20% of outstanding Class A shares or result in a change of control under Nasdaq rules. The board unanimously recommends voting in favor of all nine proposals.
Cuprina Holdings (Cayman) Limited files its Form 20-F annual report for the year ended December 31, 2025, outlining its early-stage biotech and cosmeceuticals business. The company reports net losses of S$1,119,555 in 2023, S$1,560,535 in 2024 and S$4,673,447 (US$3,633,248) in 2025.
As of December 31, 2025, Cuprina shows an accumulated deficit of S$9,234,500 (US$7,179,118) and net cash used in operating activities of S$9,133,948 (US$7,100,947). The report highlights prior net current liabilities in 2023 and 2024, dependence on IPO proceeds and shareholder financing, significant R&D needs, and extensive regulatory, competitive and operational risks around its wound care and cosmeceutical products.
Cuprina Holdings (Cayman) LTD filed a Form 3 identifying CHAN Tat Jing as an officer of the company, serving as Chief Financial Officer. The filing lists no stock or option transactions, and the transaction summary shows zero buys, sells, exercises, gifts, or other movements.
Cuprina Holdings (Cayman) LTD director and CEO QUEK David Yong Qi has filed an initial Form 3 showing indirect ownership in Class B Ordinary Shares. The filing reports 3,119,859 Class B Ordinary Shares held by Cuprina Holding Pte. Ltd. that are attributable to him through an ownership interest.
Cuprina Holding Pte. Ltd. holds a total of 14,085,000 Class B Ordinary Shares of the company, and Mr. Quek owns a 22.15% ownership interest in that entity. This Form 3 does not report new buying or selling activity; it establishes Mr. Quek’s existing indirect stake.
Cuprina Holdings (Cayman) LTD director KOH Pee Keat filed a Form 3 insider report for CUPR. The filing lists no buy, sell, acquire, or dispose transactions and shows no derivative positions in this dataset. It functions as a baseline insider ownership disclosure for this director.
Cuprina Holdings (Cayman) LTD director Teo Peng Kwang reported his existing indirect ownership of Class B Ordinary Shares. The filing shows 5,818,504 Class B Ordinary Shares held by Cuprina Holding Pte. Ltd. are attributed to him through his 41.31% interest in that entity, which in total holds 14,085,000 Class B Ordinary Shares. This Form 3 records holdings rather than any new share purchases or sales.
Cuprina Holdings (Cayman) LTD director files initial ownership report. Natasha Kaur Raina, a director of Cuprina Holdings (Cayman) LTD (ticker CUPR), submitted a Form 3, which is an initial statement of beneficial ownership of securities. The filing shows no reported transactions or derivative positions.
Cuprina Holdings (Cayman) LTD director and 10% owner LEE Jimmy Peng Siew filed an initial Form 3 reporting his indirect holdings in Class B Ordinary Shares. The filing shows 5,146,638 Class B Ordinary Shares held by Cuprina Holding Pte. Ltd. as the relevant block attributed to him.
Cuprina Holding Pte. Ltd. holds an aggregate of 14,085,000 Class B Ordinary Shares of the company, and Mr. LEE owns a 36.54% ownership interest in that entity. The filing records this position as indirect ownership, with no reported purchases, sales, or option exercises.